Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Barinthus Biotherapeutics

    NASDAQ: BRNS · Real-Time Price · USD
    1.13
    0.03 (2.54%)
    At close: Aug 20, 2025, 9:40 AM

    Barinthus Biotherapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 14.97M 802K 44.7M 268K
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 9.17M -4.64M 44.7M 268K
    Operating Income
    		 -67.97M -83.91M -4.04M -45.22M
    Interest Income
    		 2.68M 2.88M 3.1M 2K
    Pretax Income
    		 -61.23M -76.52M 850K -51.14M
    Net Income
    		 -61.07M -73.35M 5.34M -50.87M
    Selling & General & Admin
    		 29.67M 39.84M 6.39M 25.12M
    Research & Development
    		 38.25M 41.41M 41.11M 16.37M
    Other Expenses
    		 15.02M 3.46M 567K 4M
    Operating Expenses
    		 82.94M 84.72M 48.74M 45.49M
    Interest Expense
    		 53K 28K 19K 2.67M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 82.94M 84.72M 48.74M 45.49M
    Income Tax Expense
    		 -44K -3.08M -4.47M -28K
    Shares Outstanding (Basic)
    		 39.35M 38.39M 37.25M 37.19M
    Shares Outstanding (Diluted)
    		 39.35M 38.39M 38.17M 37.19M
    EPS (Basic)
    		 -1.55 -1.91 0.14 -1.37
    EPS (Diluted)
    		 -1.55 -1.91 0.14 -1.37
    EBITDA
    		 -55.37M -71.06M 6.4M -47.87M
    EBIT
    		 -61.17M -76.49M 869K -48.47M
    Depreciation & Amortization
    		 5.8M 5.45M 4.32M 601.93K

    Add to Watchlist